H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB)

Nuvation Bio Inc. (NYSE:NUVB) is one of the top strong buy stocks under $5 to buy now. In a report released on August 8, Robert Burns from H.C. Wainwright reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a price target of $10.00.

Similarly, in a report released on August 7, Leonid Timashev from RBC Capital reiterated a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) and set a price target of $7.00.

The same day, David Nierengarten from Wedbush also maintained a Buy rating on Nuvation Bio Inc. (NYSE:NUVB) with a price target of $6.00. The stock’s median price target of $2.90 implies an upside of 141.38% from current levels.

Nuvation Bio (NYSE:NUVB) is a biopharmaceutical company that develops therapeutic and differentiated candidates to tackle the gaps in oncology.

While we acknowledge the potential of NUVB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.